桂林三金(002275)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

002275 桂林三金

已收盘 12-16 15:00:00

{"stockData":{"symbol":"002275","market":"SZ","secType":"STK","nameCN":"桂林三金","latestPrice":14.37,"timestamp":1765868601000,"preClose":14.6,"halted":0,"volume":2115393,"delay":0,"changeRate":-0.0158,"floatShares":559000000,"shares":588000000,"eps":0.89,"marketStatus":"已收盘","change":-0.23,"latestTime":"12-16 15:00:00","open":14.58,"high":14.63,"low":14.35,"amount":30515100,"amplitude":0.0192,"askPrice":14.39,"askSize":73,"bidPrice":14.37,"bidSize":399,"shortable":0,"etf":0,"ttmEps":0.89,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1765935000000},"marketStatusCode":5,"adr":0,"adjPreClose":14.6,"symbolType":"stock","openAndCloseTimeList":[[1765848600000,1765855800000],[1765861200000,1765868400000]],"highLimit":16.06,"lowLimit":13.14,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":587568600,"isCdr":false,"pbRate":2.64,"roa":"--","peRate":16.146067,"roe":"12.27%","epsLYR":0.89,"committee":0.688274,"marketValue":8443000000,"turnoverRate":0.0038,"status":1,"floatMarketCap":8033000000},"requestUrl":"/m/hq/s/002275/wiki","defaultTab":"wiki","newsList":[{"id":"2591261535","title":"桂林三金：截至2025年12月10日股东总户数为19929","url":"https://stock-news.laohu8.com/highlight/detail?id=2591261535","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591261535?lang=zh_cn&edition=full","pubTime":"2025-12-15 15:31","pubTimestamp":1765783861,"startTime":"0","endTime":"0","summary":"证券之星消息，桂林三金(002275)12月15日在投资者关系平台上答复投资者关心的问题。投资者提问：您好，截止到2025年12月12日公司最近的股东户数是多少，谢谢桂林三金回复：您好，截至2025年12月10日股东总户数为19929，谢谢。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121500012796.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0188","BK0028","BK0060","002275"],"gpt_icon":0},{"id":"2590524533","title":"桂林三金（002275）披露召开2025年第二次临时股东大会通知，12月10日股价上涨0.2%","url":"https://stock-news.laohu8.com/highlight/detail?id=2590524533","media":"证券之星","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590524533?lang=zh_cn&edition=full","pubTime":"2025-12-10 22:30","pubTimestamp":1765377045,"startTime":"0","endTime":"0","summary":"截至2025年12月10日收盘，桂林三金报收于14.93元，较前一交易日上涨0.2%，最新总市值为87.72亿元。该股当日开盘14.95元，最高14.97元，最低14.82元，成交额达2349.1万元，换手率为0.28%。公司近日发布公告称，将于2025年12月26日召开2025年第二次临时股东大会，会议由公司董事会召集，现场会议时间为当日14:30，网络投票时间为当日9:15至15:00。股权登记日为2025年12月19日。其中部分议案需特别决议通过，独立董事候选人须经深交所审核无异议后方可表决。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121000042298.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0060","BK0188","BK0028","002275","BK0239"],"gpt_icon":0},{"id":"2589885128","title":"桂林三金：西瓜霜制作技艺入选桂林非遗名录","url":"https://stock-news.laohu8.com/highlight/detail?id=2589885128","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589885128?lang=zh_cn&edition=full","pubTime":"2025-12-05 09:24","pubTimestamp":1764897861,"startTime":"0","endTime":"0","summary":"证券之星消息，桂林三金(002275)12月05日在投资者关系平台上答复投资者关心的问题。投资者提问：你好，西瓜霜申请省级非遗有在推进了吗？有没有计划申请国家级的非遗。桂林三金回复：您好，“桂林三金西瓜霜制作技艺”入选桂林非遗名录，公司董事长成功获评桂林市市级非物质文化遗产项目代表性传承人。省级、国家级项目需逐级申报，目前申报工作正按照计划逐步推进，谢谢。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120500005743.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0060","BK0028","002275","BK0239","BK0188"],"gpt_icon":0},{"id":"2588039588","title":"桂林三金(002275)11月28日股东户数2.02万户，较上期减少1.73%","url":"https://stock-news.laohu8.com/highlight/detail?id=2588039588","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588039588?lang=zh_cn&edition=full","pubTime":"2025-12-02 17:44","pubTimestamp":1764668654,"startTime":"0","endTime":"0","summary":"证券之星消息，近日桂林三金披露，截至2025年11月28日公司股东户数为2.02万户，较11月20日减少356.0户，减幅为1.73%。在中药行业个股中，桂林三金股东户数低于行业平均水平，截至11月28日，中药行业平均股东户数为5.32万户。从股价来看，2025年11月20日至2025年11月28日，桂林三金区间涨幅为0.8%，在此期间股东户数减少356.0户，减幅为1.73%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120200026463.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002275","BK0028","BK0239","BK0060","BK0188"],"gpt_icon":0},{"id":"2588927086","title":"桂林三金：产品未销往欧盟国家","url":"https://stock-news.laohu8.com/highlight/detail?id=2588927086","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588927086?lang=zh_cn&edition=full","pubTime":"2025-12-02 12:12","pubTimestamp":1764648739,"startTime":"0","endTime":"0","summary":"证券之星消息，桂林三金(002275)12月02日在投资者关系平台上答复投资者关心的问题。投资者提问：注意到贵公司的产品销往17个国家，请问这其中包括欧盟国家吗？桂林三金回复：您好，公司三金片和西瓜霜在海外很多市场都有销售，如东欧的塞尔维亚、美洲的美国和加拿大、大洋洲的澳大利亚、东南亚地区大部分国家等，目前没有产品销往欧盟国家，谢谢。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120200015281.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0060","BK0028","002275","FSXEmain","FESXmain","BK0239","BK0188"],"gpt_icon":0},{"id":"2585468307","title":"桂林三金(002275)11月20日股东户数2.06万户，较上期减少4.63%","url":"https://stock-news.laohu8.com/highlight/detail?id=2585468307","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2585468307?lang=zh_cn&edition=full","pubTime":"2025-11-24 17:46","pubTimestamp":1763977616,"startTime":"0","endTime":"0","summary":"证券之星消息，近日桂林三金披露，截至2025年11月20日公司股东户数为2.06万户，较11月10日减少1001.0户，减幅为4.63%。在中药行业个股中，桂林三金股东户数低于行业平均水平，截至11月20日，中药行业平均股东户数为5.34万户。从股价来看，2025年11月10日至2025年11月20日，桂林三金区间跌幅为1.58%，在此期间股东户数减少1001.0户，减幅为4.63%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112400022577.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0028","002275","BK0188","BK0060"],"gpt_icon":0},{"id":"2583955095","title":"桂林三金：截至2025年11月10日，股东总户数为21601户","url":"https://stock-news.laohu8.com/highlight/detail?id=2583955095","media":"证券日报 ","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2583955095?lang=zh_cn&edition=full","pubTime":"2025-11-13 21:40","pubTimestamp":1763041200,"startTime":"0","endTime":"0","summary":"证券日报网讯桂林三金11月13日在互动平台回答投资者提问时表示，截至2025年11月10日，股东总户数为21601户。（文章来源：证券日报）\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2025-11-13/doc-infxhqmu3703863.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2025-11-13/doc-infxhqmu3703863.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0060","BK0188","002275","BK0239","BK0028"],"gpt_icon":0},{"id":"2582949613","title":"股市必读：桂林三金（002275）11月11日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2582949613","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582949613?lang=zh_cn&edition=full","pubTime":"2025-11-12 03:35","pubTimestamp":1762889715,"startTime":"0","endTime":"0","summary":"截至2025年11月11日收盘，桂林三金报收于15.54元，上涨1.11%，换手率0.94%，成交量5.24万手，成交额8102.0万元。来自公司公告汇总：桂林三金公布2025年前三季度分红方案，每10股派发现金股利2.00元（含税），股权登记日为2025年11月18日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111200002816.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0060","BK0188","BK0028","002275","BK0239"],"gpt_icon":0},{"id":"2582287353","title":"桂林三金：BC006单抗注射液即将完成I期临床试验","url":"https://stock-news.laohu8.com/highlight/detail?id=2582287353","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582287353?lang=zh_cn&edition=full","pubTime":"2025-11-11 15:33","pubTimestamp":1762846387,"startTime":"0","endTime":"0","summary":"证券之星消息，桂林三金(002275)11月11日在投资者关系平台上答复投资者关心的问题。投资者提问：贵公司之前预计q4 bc006项目会进入三期，现在第4季度很久了，一期临床都没有完成。是否项目进度不及预期？请说说2025年创新药部分投入情况。以及后期是否会持续加大创新药的研发？桂林三金回复：您好，目前公司产品BC006单抗注射液项目，即将完成I期临床试验。如果取得关键性突破，公司会按照深交所要求进行披露，公司后续研发投入是与研发进度相匹配的，感谢您对公司的关注。谢谢。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111100019479.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002275","BK0028","BK0060","BK0239","BK0188"],"gpt_icon":0},{"id":"2582679353","title":"桂林三金：玉叶解毒颗粒适用于外感风热引起的感冒咳嗽","url":"https://stock-news.laohu8.com/highlight/detail?id=2582679353","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582679353?lang=zh_cn&edition=full","pubTime":"2025-11-11 15:27","pubTimestamp":1762846033,"startTime":"0","endTime":"0","summary":"证券之星消息，桂林三金11月11日在投资者关系平台上答复投资者关心的问题。用于风寒感冒，头痛发热，恶寒身痛，鼻流清涕，咳嗽咽干。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111100019128.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0060","BK0188","BK0028","002275","BK0239"],"gpt_icon":0},{"id":"2582877692","title":"桂林三金（002275）披露2025年前三季度分红派息实施公告，11月10日股价上涨0.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2582877692","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582877692?lang=zh_cn&edition=full","pubTime":"2025-11-10 22:27","pubTimestamp":1762784872,"startTime":"0","endTime":"0","summary":"截至2025年11月10日收盘，桂林三金报收于15.37元，较前一交易日上涨0.26%，最新总市值为90.31亿元。该股当日开盘15.33元，最高15.45元，最低15.32元，成交额达5702.25万元，换手率为0.66%。公司近日发布公告称，2025年前三季度利润分配方案已获董事会审议通过。股权登记日为2025年11月18日，除权除息日为2025年11月19日。公司回购专用证券账户中股份为0股，不参与本次权益分派。现金红利由中国结算深圳分公司代派，部分股东由公司自行派发。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111000034776.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0060","BK0188","BK0239","002275"],"gpt_icon":0},{"id":"2581750632","title":"股市必读：桂林三金(002275)股东户数2.14万户，较上期减少1.83%","url":"https://stock-news.laohu8.com/highlight/detail?id=2581750632","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2581750632?lang=zh_cn&edition=full","pubTime":"2025-11-05 02:29","pubTimestamp":1762280950,"startTime":"0","endTime":"0","summary":"截至2025年11月4日收盘，桂林三金报收于15.16元，上涨0.13%，换手率0.65%，成交量3.62万手，成交额5471.76万元。来自股本股东变化：截至2025年10月31日，桂林三金股东户数为2.14万户，较10月20日减少1.83%，户均持股数量上升至2.74万股。投资者： 董秘您好，请问截止10月30日，贵公司股东人数是多少？董秘： 您好，截至2025年10月31日股东总户数为21419，谢谢。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110500001275.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0239","BK0060","002275","BK0028"],"gpt_icon":0},{"id":"2580270594","title":"桂林三金：目前公司没有用到该技术的创新药","url":"https://stock-news.laohu8.com/highlight/detail?id=2580270594","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2580270594?lang=zh_cn&edition=full","pubTime":"2025-11-04 12:15","pubTimestamp":1762229710,"startTime":"0","endTime":"0","summary":"证券之星消息，桂林三金(002275)11月04日在投资者关系平台上答复投资者关心的问题。投资者提问：贵公司创新药，有没有用到car-t技术？桂林三金回复：您好，公司创新药平台主要为旗下孙公司宝船生物，宝船生物聚焦肿瘤和自身免疫性疾病等治疗领域，专注于开发和筛选针对多种肿瘤和自身免疫性疾病的生物药。目前公司没有用到该技术的创新药，谢谢。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110400016946.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0060","BK1161","BK0239","06978","002275","159992","BK1574","BK0028"],"gpt_icon":0},{"id":"2579646101","title":"桂林三金（002275）2025年三季报简析：净利润同比增长0.35%，盈利能力上升","url":"https://stock-news.laohu8.com/highlight/detail?id=2579646101","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579646101?lang=zh_cn&edition=full","pubTime":"2025-10-31 06:42","pubTimestamp":1761864136,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期桂林三金发布2025年三季报。截至本报告期末，公司营业总收入14.62亿元，同比下降7.14%，归母净利润3.85亿元，同比上升0.35%。按单季度数据看，第三季度营业总收入4.64亿元，同比下降8.36%，第三季度归母净利润9840.17万元，同比上升18.69%。本报告期桂林三金盈利能力上升，毛利率同比增幅0.52%，净利率同比增幅8.07%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025103100009486.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002275"],"gpt_icon":0},{"id":"2579490415","title":"桂林三金(002275.SZ)发布前三季度业绩，归母净利润3.85亿元，同比增长0.35%","url":"https://stock-news.laohu8.com/highlight/detail?id=2579490415","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579490415?lang=zh_cn&edition=full","pubTime":"2025-10-29 21:47","pubTimestamp":1761745635,"startTime":"0","endTime":"0","summary":"智通财经APP讯，桂林三金(002275.SZ)发布2025年三季度报告，前三季度，公司实现营业收入14.62亿元，同比下降7.14%。归属于上市公司股东的净利润3.85亿元，同比增长0.35%。归属于上市公司股东的扣除非经常性损益的净利润3.53亿元，同比增长1.70%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1362239.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["002275"],"gpt_icon":0},{"id":"2579794289","title":"桂林三金（002275）披露2025年前三季度利润分配方案，10月29日股价上涨1.2%","url":"https://stock-news.laohu8.com/highlight/detail?id=2579794289","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579794289?lang=zh_cn&edition=full","pubTime":"2025-10-29 18:19","pubTimestamp":1761733163,"startTime":"0","endTime":"0","summary":"近日，桂林三金发布《关于2025年前三季度利润分配方案的公告》。公告显示，公司于2025年10月28日召开第八届董事会第十五次会议及第八届监事会第十一次会议，审议通过《2025年前三季度利润分配方案》。按现有总股本587,568,600股计算，预计分配现金股利117,513,720.00元(含税)。该方案在2024年度股东大会授权范围内，无需提交股东大会审议。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushiyaowen/20251029/31747659.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK0028","002275","BK0239","BK0188","BK0060"],"gpt_icon":0},{"id":"2579015929","title":"桂林三金：截至2025年10月20日股东总户数为21818","url":"https://stock-news.laohu8.com/highlight/detail?id=2579015929","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579015929?lang=zh_cn&edition=full","pubTime":"2025-10-29 15:39","pubTimestamp":1761723570,"startTime":"0","endTime":"0","summary":"证券之星消息，桂林三金(002275)10月29日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘您好！请问截止10月20号，公司的股东人数是多少？谢谢桂林三金回复：您好，截至2025年10月20日股东总户数为21818，谢谢。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102900027831.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","002275","BK0028","BK0060","BK0239"],"gpt_icon":0},{"id":"2576008256","title":"股市必读：桂林三金（002275）10月17日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2576008256","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2576008256?lang=zh_cn&edition=full","pubTime":"2025-10-20 02:58","pubTimestamp":1760900290,"startTime":"0","endTime":"0","summary":"截至2025年10月17日收盘，桂林三金报收于14.92元，下跌1.39%，换手率0.68%，成交量3.78万手，成交额5699.68万元。董秘最新回复投资者： 董秘您好。董秘： 您好，目前公司产品BC006单抗注射液项目，即将完成I期临床试验。谢谢董秘： 您好，截至2025年09月30日股东总户数为21448，谢谢。当日关注点来自交易信息汇总：10月17日主力资金净流出762.65万元，显示主力短期减持动向。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102000001107.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0060","002275","BK0188","BK0028"],"gpt_icon":0},{"id":"2575710377","title":"桂林三金：公司创新药平台主要为旗下孙公司宝船生物","url":"https://stock-news.laohu8.com/highlight/detail?id=2575710377","media":"证券日报 ","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2575710377?lang=zh_cn&edition=full","pubTime":"2025-10-16 18:08","pubTimestamp":1760609280,"startTime":"0","endTime":"0","summary":"证券日报网讯桂林三金10月16日在互动平台回答投资者提问时表示，公司创新药平台主要为旗下孙公司宝船生物，宝船生物聚焦肿瘤和自身免疫性疾病等治疗领域，专注于开发和筛选针对多种肿瘤和自身免疫性疾病的生物药。在研项目共计17个，其中正式管线项目6个，新药发现阶段项目4个，平台建设项目6个，预研项目1个（含27个子项目）。目前公司产品BC006单抗注射液项目，即将完成I期临床试验。（文章来源：证券日报）\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2025-10-16/doc-infuauti2451199.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2025-10-16/doc-infuauti2451199.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["002275","BK1574","BK0188","BK0060","BK1161","BK0028","BK0239","06978","159992"],"gpt_icon":0},{"id":"2575710307","title":"桂林三金：公司有一套切实可行的市值管理策略","url":"https://stock-news.laohu8.com/highlight/detail?id=2575710307","media":"证券日报 ","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2575710307?lang=zh_cn&edition=full","pubTime":"2025-10-16 18:08","pubTimestamp":1760609280,"startTime":"0","endTime":"0","summary":"证券日报网讯桂林三金10月16日在互动平台回答投资者提问时表示，二级市场股价的波动，受宏观经济环境、估值水平、市场情绪等诸多因素的影响。公司有一套切实可行的市值管理策略，正在稳步实施，目的在于使公司股价与公司内在价值相匹配。在基本面，公司致力于通过加强技术创新、提高产品销量、改善企业管理等方面来提升公司的盈利能力，实现公司利润持续稳定的增长，为股东创造更大的价值。（文章来源：证券日报）\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2025-10-16/doc-infuauti2451134.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2025-10-16/doc-infuauti2451134.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["002275","BK0028","BK0060","BK0239","BK0188"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1765915101581,"stockEarnings":[{"period":"1week","weight":-0.0356},{"period":"1month","weight":-0.0673},{"period":"3month","weight":-0.0202},{"period":"6month","weight":0.0275},{"period":"1year","weight":0.0003},{"period":"ytd","weight":-0.011}],"compareEarnings":[{"period":"1week","weight":-0.0217},{"period":"1month","weight":-0.0415},{"period":"3month","weight":-0.0133},{"period":"6month","weight":0.1376},{"period":"1year","weight":0.1295},{"period":"ytd","weight":0.1411}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"桂林三金药业股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"19929人(较上一季度减少1.56%)","perCapita":"0股","listingDate":"2009-07-10","address":"广西壮族自治区桂林市临桂区人民南路9号","registeredCapital":"58756万元","survey":"　　桂林三金药业股份有限公司的主营业务是中成药的研发、制造与销售。公司的主要产品是三金片、桂林西瓜霜、西瓜霜润喉片、西瓜霜清咽含片、眩晕宁片/颗粒、蛤蚧定喘胶囊、拉莫三嗪片（安闲）、脑脉泰胶囊、玉叶解毒颗粒、复方田七胃痛胶囊。公司获评国家知识产权示范企业、中华民族医药优秀品牌企业、首批全国工商联科技创新民营企业等荣誉，在西普会上重磅发布的“2024中成药工业综合竞争力50强”榜单中，公司位列第44位。","listedPrice":19.8},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"桂林三金(002275)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供桂林三金(002275)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"桂林三金,002275,桂林三金股票,桂林三金股票老虎,桂林三金股票老虎国际,桂林三金行情,桂林三金股票行情,桂林三金股价,桂林三金股市,桂林三金股票价格,桂林三金股票交易,桂林三金股票购买,桂林三金股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"桂林三金(002275)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供桂林三金(002275)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}